Resources

Neonatal infections are a major cause of newborn mortality in low-resource settings. In view of the World Health Organization’s new 2015 guidelines for outpatient treatment of neonatal sepsis when referral is not feasible, PATH reviewed a range of drug formulation, packaging, and delivery technologies that might be applied to gentamicin delivery for infants at primary care to improve safety, ease of delivery, and potentially expand access.

This table shows the landscape of commercially available stationary and portable oxygen concentrators and related devices.

The Woman’s Condom has been evaluated for acceptability, performance, and safety in clinical studies across five countries since 2004. This document provides summaries of the key studies implemented during development and validation of the Woman’s Condom as a new method for dual protection.

This document describes a quality assurance (QA) program for Ov16 rapid tests that can be implemented by onchocerciasis control and elimination programs to help ensure high-quality testing and to identify areas for improvement and change. Designed for policymakers and program planners wishing to implement Ov16 rapid testing, these guidelines describe some important basic principles and the main practical aspects of a QA program.

Zambia has made significant progress in improving the health of its women and children. However, many still lack access to basic care. In 2015, PATH conducted an assessment of global initiatives, national policies, and decision-making factors influencing the delivery, accessibility, and availability of 13 basic cost-effective reproductive, maternal, newborn, and child health commodities.